Search for: "ACTAVIS" Results 141 - 160 of 1,004
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2016, 2:17 am by Aida Tohala
The issues in this case were remitted by the Court of Appeal in its June 2015 decision overturning the grant of DNIs regarding the same European Patent, which was based on reconstitution of Actavis’ pemetrexed product in saline (Actavis UK Limited v Eli Lilly & Company [2015] EWCA Civ 555). [read post]
25 Aug 2016, 9:00 pm by Patent Docs
• Defendants: Actavis Elizabeth LLC; Actavis Inc. [read post]
3 Jul 2018, 10:21 am by Sara Moran
  More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post Actavis UK Limited v Eli Lilly, Supreme Court of the United Kingdom, [2017] UKSC 48, 12 July 2017 appeared first on Kluwer Patent Blog. [read post]
28 Oct 2013, 12:43 pm by Gene Quinn
Mouse Model of Parkinson's Disease Shows Improved Brain Function --- DARPA Awards $25 Million To Develop Messenger RNA Therapeutics™ --- Actavis Files ANDA for Generic Suboxone® Sublingual Film --- AzaSite® Patents Upheld in Patent Infringement Lawsuit Against Sandoz --- Surgeons Successfully Remove "Inoperable" Metastatic Breast Cancer --- Actavis Files ANDA on Acanya® Gel, Gets Sued by Dow, Valeant --- NYSE Inquires About Unusual Market Activity for Ampio… [read post]
2 May 2014, 5:00 am by Gene Quinn
Supreme Court Denies Teva's Request for an Injunction Relating to Generic Copaxone® --- Actavis Announces Celebrex® Patent Challenge Settlement --- Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014. [read post]
6 Nov 2013, 9:35 pm by Patent Docs
This referral follows three earlier referrals to the CJEU concerning the interpretation of the SPC Regulation in the cases of Actavis v Sanofi, Lilly v Human Genome Sciences and Georgetown University. [read post]
2 May 2014, 5:00 am by Gene Quinn
Supreme Court Denies Teva's Request for an Injunction Relating to Generic Copaxone® --- Actavis Announces Celebrex® Patent Challenge Settlement --- Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014. [read post]
17 Oct 2013, 12:42 pm
 He therefore permitted Actavis's wording in respect of the Actavis group. [read post]
28 Jun 2015, 4:53 am
The ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year. [read post]
18 Jun 2013, 10:24 am by Michael Carrier
In this case, the Supreme Court considered an arrangement by which brand firm Solvay paid generics Watson (now Actavis) and Paddock roughly $30 to $40 million to delay entering the market with generic versions of testosterone gel. [read post]
13 Aug 2008, 8:46 pm
Last week, Digitek manufacturer Actavis Totowa recalled over 65 different drugs made at their New Jersey manufacturing plant. [read post]
2 Jun 2008, 7:41 pm by Larry Jones
A Digitek class action lawsuit has been filed in US District Court in New Jersey against the Icelandic prescription drug maker, Actavis Group. [read post]
7 Jul 2017, 8:53 am by Brian Cordery
The Court has also dismissed Actavis’ cross-appeal and held that Actavis’ products would also indirectly infringe Eli Lilly’s patent to the extent held by the Court of Appeal. [read post]
7 Jul 2017, 8:53 am by Brian Cordery
The Court has also dismissed Actavis’ cross-appeal and held that Actavis’ products would also indirectly infringe Eli Lilly’s patent to the extent held by the Court of Appeal. [read post]
29 Dec 2018, 6:30 am by Sara Moran
Sara MoranApplying the so-called ‘Actavis Questions’ (further to the Supreme Court decision in Actavis v Eli Lilly), the Court of Appeal reached a different conclusion from the Patents Court on the issue of infringement. [read post]
14 Jul 2008, 8:54 pm
Lawyers representing Digitek overdose victims have filed nine lawsuits in New Jersey against Actavis Totowa LLL and its parent company Actavis Group, alleging a manufacturing defect in Digitek, namely that some Digitek tablets have contained twice the active ingredient of the drug. [read post]